Anzeige
Mehr »
Sonntag, 14.12.2025 - Börsentäglich über 12.000 News
Breaking News: Parazero Technologies und die Bundespolizei!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P27V | ISIN: US01609Y1082 | Ticker-Symbol: TWYA
Siehe auch ALIBABA HEALTH INFORMATION TECHNOLOGY LTD
Frankfurt
12.12.25 | 08:03
9,700 Euro
-2,51 % -0,250
Branche
IT-Dienstleistungen
Aktienmarkt
ASIEN
1-Jahres-Chart
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD ADR Chart 1 Jahr
5-Tage-Chart
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD ADR 5-Tage-Chart

Aktuelle News zur ALIBABA HEALTH INFORMATION TECHNOLOGY LTD ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoALI HEALTH (00241): FISCAL YEAR 2026 INTERIM REPORT4
DoHSI Closes at 25,530, Down 10 pts; HSTI Closes at 5,534, Down 46 pts; ALI HEALTH Down over 3%; HANSOH PHARMA Hit New Highs; Market Turnover Rises4
DoHSI Closes Midday at 25,563, Up 22 pts; HSTI Closes Midday at 5,544, Down 36 pts; ALI HEALTH Down over 3%; HANSOH PHARMA Hit New Highs2
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD ADR Aktie jetzt für 0€ handeln
MoALI HEALTH (00241): FORM OF PROXY FOR USE AT THE SPECIAL GENERAL MEETING (OR AT ANY ADJOURNMENT THEREOF)2
MoALI HEALTH (00241): NOTICE OF SPECIAL GENERAL MEETING1
MoALI HEALTH (00241): CONTINUING CONNECTED TRANSACTION - REVISION OF ANNUAL CAPS FOR 2025-2027 MARKETING AND PROMOTION SERVICES FRAMEWORK AGREEMENT AND ...1
MoCLSA Foresees JD HEALTH, ALI HEALTH to Achieve Double-Digit Rev. Growth Next Yr4
05.12.ALI HEALTH, Beijing Tong Ren Tang Forge Strategic Co-op to Build Service Loop for Cardiovascular & Cerebrovascular Chronic Diseases3
03.12.JPM Expects Continued Growth in ALI HEALTH Future Platform Sales, Keeps Neutral Rating2
02.12.Alibaba Health: UBS hebt Kursziel an, bestätigt aber Verkaufsempfehlung13
02.12.UBS raises Alibaba Health price target to HK$4.70, maintains Sell rating2
02.12.G Sachs Adds TP to $5.2, Expects ALI HEALTH FY2026 Results Guidance Still Has Upside3
02.12.UBS Lifts ALI HEALTH's TP to HKD4.7; Rating Kept Sell2
28.11.CLSA: ALI HEALTH 1HFY26 Results Slightly Beat6
28.11.CICC: ALI HEALTH TP Lifted to $7.1 as Strengthened Strategic Co-op with Upstream Firms to Expand Biz7
27.11.HSI Closes Up 17 Pts on Settlement Date as POP MART Gains; ALI HEALTH Sags 5%+18
27.11.HSI Settles Midday Up 86 Pts; POP MART Soars 8%+; ALI HEALTH Retreats Post-Results7
27.11.Citi: ALI HEALTH Interim Rev. & NP Beat; Focus on Potential Raising of Results Guidance5
26.11.ALI HEALTH (00241): CONTINUING CONNECTED TRANSACTION - REVISION OF ANNUAL CAPS FOR 2025-2027 MARKETING AND PROMOTION SERVICES FRAMEWORK AGREEMENT5
26.11.ALI HEALTH (00241): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED SEPTEMBER 30, 20254
Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1